U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease – CNBC
- U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease CNBC
- FDA expected to approve first CRISPR gene-editing treatment, bringing hope to thousands with sickle cell disease CNN
- Gene editing could be a game changer for patients with sickle cell disease CBS Mornings
- The Download: inside the first CRISPR treatment, and smarter robots MIT Technology Review
- FDA Approves World’s First Crispr Gene-Editing Drug for Sickle-Cell Disease The Wall Street Journal
Source: Air Tools